Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins.
Saved in:
| Title: | Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins. |
|---|---|
| Authors: | Leach, Adam1, Miller, Ami1,2, Bentley, Emma3, Mattiuzzo, Giada3, Thomas, Jemima1, McAndrew, Craig1, Van Montfort, Rob1, Rabbitts, Terence1 terry.rabbitts@icr.ac.uk |
| Source: | Scientific Reports. 5/18/2021, Vol. 11 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-021-89887-w |
